Characterization of non-motor symptoms in patients with Parkinson's disease

Authors

Keywords:

Parkinson's disease, Non-motor symptoms.

Abstract

Introduction: Parkinson's disease is one of the most frequent degenerative diseases and is characterized by non-motor clinical manifestations.

Objective: to characterize the non-motor clinical manifestations of patients suffering from Parkinson's disease.

Methods: an observational, descriptive, cross-sectional study was conducted.  The universe consisted of patients with Parkinson's disease who attended the movement disorders consultation of the Carlos Manuel de Céspedes General Provincial Hospital in the period from July 1, 2020 to December 31, 2020, while the sample was made up of patients who completed all clinimetric tests and who gave their informed consent to participate in the study.

Results: the mean age was 69.05 years, predominantly male. The average scores of the Montreal Cognitive Assessment and the Unified Parkinson's Disease Scale modified by the Society for Movement Disorders (part I) were 17.95 and 9.85 respectively.

Conclusions: The most affected domains were: urinary, gastrointestinal and sleep/fatigue. The average score obtained when applying the Montreal Cognitive Assessment was low.  The non-motor impact of Parkinson's disease on daily life experiences was high.

 

Downloads

Download data is not yet available.

References

1. Savica R, Grossardt BR, Rocca WA, Bower JH. Parkinson disease with and without Dementia: A prevalence study and future projections. Mov Disord 2018 Apr; 33(4): 537- 43.

2. Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna) 2017; 124(8): 901-5.

3. Park JH, Kim DH, Kwon DY, Choi M, Kim S, Jung JH, et al. Trends in the incidence and prevalence of Parkinson’s disease in Korea: a nationwide, population-based study. BMC Geriatr. [Internet]. 2019 [citado 18/10/2022]; 320. Disponible en: file:///C:/Users/Lucy/Downloads/s12877-019-1332-7.pdf

4. Yu RL, Wu RM, Chan AY, Mok V, Wu YR, Tilley BC, et al. Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson’s Disease Rating Scale. Mov Disord Clin Pract 2016; 4(1): 68-77.

5. Salari M, Chitsaz A, Etemadifar M, Najafi MR, Mirmosayyeb O, Bemanalizadeh M, et al. Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson's disease, Isfahan, Iran. Iran J Neurol. 2017 Jul 6; 16(3): 118-24.

6. Valent F, Devigili G, Rinaldo S, Del Zotto S, Tullio A, Eleopra R. The epidemiology of Parkinson's disease in the Italian region Friuli Venezia Giulia: a population-based study with administrative data. Neurol Sci. 2018 Apr; 39(4): 699-704.

7. Rodríguez Violante M, Velásquez Pérez L, Cervantes Arriaga A. Incidence rates of Parkinson’s disease in Mexico: Analysis of 2014-2017 statistics. Rev Mex Neurocienc 2019; 20(3): 136-40.

8. Giroud JL, Esteban EM, Collado Mesa F. Prevalencia de la enfermedad de Parkinson en un área urbana de la provincia Ciudad de La Habana, Cuba. Estudio poblacional. Neurol Publ Soc Esp Neurol 2000; 15(7): 269-73.

9. Argüelles JL, Borroto Bermudez LA, Sosa Aguila LM, Rodriguez Carbajal A. Prevalence of Parkinson’s disease in an urban area of Cienfuegos city. Int J Fam Commun Med 2019; 3(1): 12- 4.

10. Kelly MJ, Lawton MA, Baig F, Ruffmann C, Barber TR, Lo C, et al. Predictors of motor complications in early Parkinson's disease: A prospective cohort study. Mov Disord 2019 Aug; 34(8): 1174- 83.

11. Sánchez Martínez CM, Choreño Parra JA, Placencia Álvarez N, Nuñez Orozco L, Guadarrama Ortiz P. Frequency and Dynamics of Non-motor Symptoms Presentation in Hispanic Patients With Parkinson Disease. Front Neurol 2019; 10: 1197-210.

12. Georgiev D, Hamberg K, Hariz M, Forsgren L, Hariz GM. Gender differences in Parkinson's disease: A clinical perspective. Acta Neurol Scand 2017 Dec; 136(6): 570-84.

13. Merola A, Romagnolo A, Rosso M, Suri R, Berndt Z, Maule S, et al. Autonomic dysfunction in Parkinson's disease: A prospective cohort study. Mov Disord 2018 Mar; 33(3): 391- 7.

14. Arguedas Vásquez K, Miranda Valverde E, Valerio Aguilar D, Hernández Gabarain H. Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination. Dement Neuropsychol. 2019 Jan-Mar; 13(1): 78-81.

15. Chen YC, Huang YZ, Weng YH, Chen CC, Hung J, Lin YY, et al. Nonmotor symptoms of 820 Taiwanese patients with Parkinson's disease: an exploratory-comparative study. J Neurol. 2020 May; 267(5): 1499-507.

16. Picillo M, Palladino R, Barone P, Erro R, Colosimo C, Marconi R, et al. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease. Eur J Neurol 2017 Jun; 24(6): 788-95.

17. Vurture G, Peyronnet B, Palma JA, Sussman RD, Malacarne DR, Feigin A, et al. Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease. Int Neurourol J 2019 Sep; 23(3): 211-8.

18. Wang J, Cao R, Huang T, Liu C, Fan Y. Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease. Parkinsons Dis. 2020 Nov 28; 2020: 4981647.

19. Jones JD, Rahmani E, Garcia E, Jacobs JP. Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson's disease. Parkinsonism Relat Disord 2020 Mar; 72: 7-12.

20. Lawton M, Baig F, Toulson G, Morovat A, Evetts SG, Ben-Shlomo Y, et al. Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort. Mov Disord 2020 Feb; 35(2): 279-87.

21. Lawton M, Ben Shlomo Y, May MT, Baig F, Barber TR, Klein JC, et al. Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression. J Neurol Neurosurg Psychiatry 2018; 89(12): 1279-87.

Downloads

Published

2022-11-23

How to Cite

1.
Verdecia Aguilar M, Jacas Cabrera A, Milanés Domínguez J, Frias Viltres D, Odoardo Aguilar M. Characterization of non-motor symptoms in patients with Parkinson’s disease. RM [Internet]. 2022 Nov. 23 [cited 2025 Jun. 20];26(5):e2471. Available from: https://revmultimed.sld.cu/index.php/mtm/article/view/2471

Issue

Vol. 26 No. 5 (2022): Septiembre - Octubre

Section

ARTÍCULOS ORIGINALES

License

Avisos de derechos de autor propuestos por Creative Commons

1. Política propuesta para revistas que ofrecen acceso abierto

Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
  1. Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).